[Featured Stock] ABION Rises 10% on News of Major Shareholder Change
ABION is surging following news of a change in its largest shareholder.
As of 2:49 PM on the 19th, ABION is trading at 6,720 KRW, up 10.89% (660 KRW) from the previous trading day.
Hot Picks Today
“Everyone Said You’d Make Money” ? Chinese I...
- Shaken Again... "Should I Just Cancel My Trip to Japan?" Heightened Tension as E...
- 'Three Cups a Day' Coffee Linked to Higher Muscle Mass... Seoul National Univers...
- "Isn't Pain Supposed to Be Good?"...Descending Stairs Is More Effective Than Cli...
- Once a Leading 'Outdoor Legend'...Is Nepa Headed Down the Same Path as Homeplus?...
Earlier, Telcon RF Pharmaceutical announced that it became the largest shareholder by purchasing 2,508,381 common shares of ABION through a block deal (off-hours trading) on the same day. The stake amounts to 20.37%. ABION has disclosed that it is conducting a global Phase 2 clinical trial for its anticancer drug 'ABN401 (Babamekip)'.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
